Pfizer · NSE: PFIZER · BSE: 500680
Q1 FY23 results · Apr–Jun 2022
Pfizer reported revenue from operations of ₹592.90 crore (down 20.9% from Q1 FY22) and net profit of ₹32.55 crore (down 83.7% from Q1 FY22) for Q1 FY23 (Apr–Jun 2022), on a standalone basis.
| Item | Q1 FY23 | Q1 FY22 | YoY | Q4 FY22 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 592.90 | 749.17 | −20.9% | 549.66 | +7.9% |
| Other income | 18.02 | 12.24 | +47.2% | 17.12 | +5.3% |
| Total income | 610.92 | 761.41 | −19.8% | 566.78 | +7.8% |
| Profit before tax | 43.39 | 268.73 | −83.9% | 145.11 | −70.1% |
| Net profit for the period | 32.55 | 199.91 | −83.7% | 125.79 | −74.1% |
| EPS, basic (₹) | 7.11 | 43.69 | −83.7% | 27.50 | −74.1% |
| Net margin (%) | 5.5 | 26.7 | 22.9 |
Standalone
- Filed with BSE
- 08 Aug 2022, 11:25 IST
- Board meeting
- 05 Aug 2022
- Period
- 01 Apr 2022 to 30 Jun 2022
- Review status
- Unaudited
- Source
- XBRL filing on BSE